Skip to content
DefDex

Federal award

REJUVENATE BIO INC.

H9240519C0004

ContractSBIR/STTR SR2

Obligated and Ceiling

Obligated (net)
$1,975,972.00
Ceiling (potential value, not spending)
$1,975,972.00
Current value
$1,975,972.00
Gross positive obligations
$1,975,972.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
REJUVENATE BIO INC. · GEKFSVSTKK55
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
REJUVENATE BIO INC. · GEKFSVSTKK55
Awarding agency
Department of War · sub-agency 9763 · office S0514A
Funding agency
Department of War · sub-agency 97ZS
Product or service (PSC)
AZ13 · R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT)
Industry (NAICS)
541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PIID
H9240519C0004
Award type code
D
Actions
11 · Nov 29, 2018 to Mar 13, 2023
Why it is listed
gross positive obligations of $100k or more (contracts); SBIR/STTR award

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Mar 13, 2023FY2023ARZ998W$0.00
—
Jun 14, 2022FY2022P00010M$0.00
—
Aug 16, 2021FY2021P00009M$0.00
—
Jun 23, 2021FY2021P00008B$0.00
—
Apr 17, 2020FY2020P00007B$0.00
—
Feb 25, 2020FY2020P00006B$534,705.00
—
Oct 29, 2019FY2020P00005C$441,267.00
—
Apr 3, 2019FY2019P00004M$0.00
—
Feb 5, 2019FY2019P00003M$0.00
—
Dec 7, 2018FY2019P00002M$0.00
—
Nov 29, 2018FY20190—$1,000,000.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.